Proactive Investors Australia | Cellmid awarded Japanese patent for autoimmune disorder treatment with ... Proactive Investors Australia This adds to its patent coverage and follows its receiving earlier this month of a European patent for the use of anti-midkine antibodies to prevent and treat cancer, inflammatory and autoimmune diseases. The European patent is the most important ... Cellmid Ltd, Key Antibody Patent Granted in Japan |
